May 2015

New Product - Velphoro

Velphoro (sucroferric oxyhydroxide) works by binding phosphate in the GI tract. Serum phosphorus levels are reduced as a consequence of the reduced dietary phosphate absorption. Velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis. It is contraindicated in those with haemochromatosis and any other iron accumulation disorders. Velphoro is available as a chewable tablet containing 2,500 mg of sucroferric oxyhydroxide (equivalent to 500 mg iron) in bottles of 90’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au